A controlled-release oral therapy has been developed by scientists that reversed type 2 diabetes and fatty liver disease in rats, according to a study. "Given these promising results in animal models of NAFLD/NASH and type 2 diabetes we are pursuing additional preclinical safety studies to take this mitochondrial protonophore approach to the clinic" said the researchers.
from News -- ScienceDaily http://ift.tt/1BChmsh via Karis World
from News -- ScienceDaily http://ift.tt/1BChmsh via Karis World
No comments:
Post a Comment